Exploratory Center of Excellence for Advancing Multimorbidity Science (CAMS)

促进多种疾病科学卓越探索中心 (CAMS)

基本信息

  • 批准号:
    10121495
  • 负责人:
  • 金额:
    $ 37.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-13 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract – Parent Study The parent study to this application is the Center for Advancing Multimorbidity Science (CAMS, P20 NR018081-01, PI: Gardner and Rakel). Many people with chronic disease have more than one chronic condition, which is referred to as multimorbidity (multiple chronic conditions: MCC). Patients with MCC have worse health outcomes, including decreased functioning and quality of life as well as greater depression, psychological distress, and mortality. However, little data exist on MCCs risk and treatment profiles to provide direction for clinical practice guidelines development. The specific aims of the parent study are to: 1. Develop a sustainable interdisciplinary biobehavioral research capacity by establishing and coordinating an infrastructure and resources that facilitates the integration of Multimorbidity and Symptom Science through the development of patient risk and therapy responder profiles. 2. Build thematic science beginning with a reconceptualization of the science of Multiple Chronic Conditions (Multimorbidity) to include Symptom Science. 3. Enable research that will develop into new programs of science and independent investigator research applications. Project Summary/Abstract – Administrative Supplement There is very little in the literature on MCC patterns and their associated pain symptomology for patients with Alzheimer’s disease (AD). This supplemental study will investigate relationships among MCC, pain symptomology, healthcare utilization, and AD. We will leverage big data in a healthcare dataset to describe the most clinically relevant MCC patterns in patients with AD and to characterize the pain symptomology and healthcare utilization. The aims of this study are: 1. Identify and describe the most frequent, highly correlated, and clinically relevant patterns of co-occurring chronic conditions among AD patients. 2. Characterize healthcare utilization and pain symptomology for the MCC patient subgroups identified in Aim 1 and compare among the subgroups. 3. Investigate the relationships between healthcare utilization and pain symptomology and MCC subgroups. The results of this study will inform the prioritization of future research leading to clinical guidelines based on patient profiles that will optimize pain treatments and outcomes for patients with AD and MCC.
项目总结/摘要-母研究 该申请的母公司研究是推进多形态科学中心(CAMS, P20 NR 018081 -01,PI:Gardner和Rakel)。许多患有慢性病的人 一种慢性疾病,称为多发病(多种慢性疾病: MCC)。MCC患者的健康状况更差,包括功能下降, 生活质量以及更大的抑郁、心理困扰和死亡率。不过小 存在关于MCC风险和治疗概况的数据,为临床实践指南提供指导 发展母研究的具体目的是: 1.发展可持续的跨学科生物行为研究能力,建立 并协调基础设施和资源,以促进 通过患者风险的发展, 治疗应答者特征。 2.建立主题科学,从多元科学的重新概念化开始 慢性疾病(多发病),包括症状科学。 3.使研究能够发展成为新的科学和独立的项目 调查员研究应用。 项目概要/摘要-行政补充 关于MCC模式及其相关疼痛病理学的文献很少, 阿尔茨海默病(AD)患者。本补充研究将调查 在MCC、疼痛病理学、医疗保健利用和AD中。我们将利用大数据, 医疗保健数据集,以描述AD患者中最具临床相关性的MCC模式, 以表征疼痛病理学和医疗保健利用。本研究的目的是: 1.识别并描述最常见、高度相关和临床相关的模式 在AD患者中同时发生的慢性疾病。 2.描述MCC患者的医疗保健利用和疼痛病理学特征 目标1中确定的亚组,并在亚组之间进行比较。 3.调查医疗保健利用与疼痛病理学之间的关系, MCC分组。 这项研究的结果将为未来的临床研究提供优先考虑。 基于患者资料的指南,将优化患者的疼痛治疗和结局 AD和MCC。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUE E GARDNER其他文献

SUE E GARDNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUE E GARDNER', 18)}}的其他基金

Center for Advancing Multimorbidity Science: Profiling risk and symptom expression to develop customized therapies for adults with multiple chronic conditions (CAMS)
促进多发病科学中心:分析风险和症状表达,为患有多种慢性病的成人开发定制疗法 (CAMS)
  • 批准号:
    10416002
  • 财政年份:
    2018
  • 资助金额:
    $ 37.47万
  • 项目类别:
Center for Advancing Multimorbidity Science: Profiling risk and symptom expression to develop customized therapies for adults with multiple chronic conditions (CAMS)
促进多发病科学中心:分析风险和症状表达,为患有多种慢性病的成人开发定制疗法 (CAMS)
  • 批准号:
    9762982
  • 财政年份:
    2018
  • 资助金额:
    $ 37.47万
  • 项目类别:
Center for Advancing Multimorbidity Science: Profiling risk and symptom expression to develop customized therapies for adults with multiple chronic conditions (CAMS)
促进多发病科学中心:分析风险和症状表达,为患有多种慢性病的成人开发定制疗法 (CAMS)
  • 批准号:
    10416003
  • 财政年份:
    2018
  • 资助金额:
    $ 37.47万
  • 项目类别:
Severe Pain During Wound Care Procedures: Model and Mechanisms
伤口护理过程中的剧烈疼痛:模型和机制
  • 批准号:
    9244682
  • 财政年份:
    2015
  • 资助金额:
    $ 37.47万
  • 项目类别:
Severe Pain During Wound Care Procedures: Model and Mechanisms
伤口护理过程中的剧烈疼痛:模型和机制
  • 批准号:
    9070786
  • 财政年份:
    2015
  • 资助金额:
    $ 37.47万
  • 项目类别:
Severe Pain During Wound Care Procedures: Model and Mechanisms
伤口护理过程中的剧烈疼痛:模型和机制
  • 批准号:
    8896199
  • 财政年份:
    2015
  • 资助金额:
    $ 37.47万
  • 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
  • 批准号:
    8070041
  • 财政年份:
    2007
  • 资助金额:
    $ 37.47万
  • 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
  • 批准号:
    7626756
  • 财政年份:
    2007
  • 资助金额:
    $ 37.47万
  • 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
  • 批准号:
    7320380
  • 财政年份:
    2007
  • 资助金额:
    $ 37.47万
  • 项目类别:
Bioburden Predictors of Diabetic Ulcer Complications
糖尿病溃疡并发症的生物负载预测因子
  • 批准号:
    7480996
  • 财政年份:
    2007
  • 资助金额:
    $ 37.47万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了